19-39707321-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020129.3(LGALS14):āc.236A>Gā(p.Tyr79Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020129.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS14 | ENST00000392052.8 | c.236A>G | p.Tyr79Cys | missense_variant | 3/4 | 1 | NM_020129.3 | ENSP00000375905.2 | ||
LGALS14 | ENST00000360675.7 | c.323A>G | p.Tyr108Cys | missense_variant | 4/5 | 3 | ENSP00000353893.2 | |||
LGALS14 | ENST00000601802.1 | c.185A>G | p.Tyr62Cys | missense_variant | 2/3 | 5 | ENSP00000471660.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251116Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135702
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461792Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727196
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.323A>G (p.Y108C) alteration is located in exon 4 (coding exon 3) of the LGALS14 gene. This alteration results from a A to G substitution at nucleotide position 323, causing the tyrosine (Y) at amino acid position 108 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at